Table 2.
Human malignancies with gain of MCM8 gene copy number
| Malignancy | % | Average gains |
|---|---|---|
| Prostate cancer | ||
| Yu et al | 19 | 3.86 |
| TCGA | 8 | 2.76 |
| Bladder cancer (TCGA) | 32 | 2.7 |
| Breast cancer (TCGA) | 40.6 | 3.16 |
| Colon cancer (TCGA | 63.5 | 3.23 |
| Esophageal carcinoma (TCGA) | 48.8 | 2.78 |
| Glioblastoma Multiforme (TCGA) | 36.1 | 2.76 |
| Liver cancer (TCGA) | 30.4 | 2.89 |
| Non-small cell lung cancer | ||
| Adenocarcinoma (TCGA) | 26.1 | 2.75 |
| Squamous cell carcinoma (TCGA) | 32.1 | 2.74 |
| Pancreas adenocarcinoma (TCGA) | 18.4 | 2.7 |
| Head and Neck squamous cell carcinoma (TCGA) | 22.6 | 2.6 |
| Acute myeloid leukemia(TCGA) | 16.9 | 3.2 |
| Ovarian cancer (TCGA) | 61.5 | 3.03 |
| Rectum adenocarcinoma (TCGA) | 79.7 | 3.27 |
| Sarcoma (TCGA) | 31.8 | 2.82 |
| Thyroid carcinoma (TCGA) | 4.2 | 2.86 |
| Uterine corpus endometrial carcinoma (TCGA) | 26.6 | 2.82 |